Evidence map›Paper›PMID 42724690›Full record

ArticleJournal of thoracic disease2026

Myocardial infarction and lung cancer research from 1995 to 2026: a WoSCC- and PubMed-based bibliometric analysis.

Xiaojie Zheng, Yang Liu, Wenzhong Chen, Xuehua Chen, Ting Li, Yining Dai, Xuan Teng, Weiyi Kong, Zongrong Lin, Zhenyang Fu and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xiaojie Zheng *Department of Medical Oncology, Cancer Hospital of Shantou University Medical College, Shantou, China.
Yang Liu *Department of Cardiology, The First Affiliated Hospital of Guangdong Pharmaceutical University, The First Clinical Medical School of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, China.
Wenzhong Chen *Department of Cardiology, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Xuehua Chen *Department of Pathology, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Ting Li *Department of International Medical Services, Cancer Hospital of Shantou University Medical College, Shantou, China.
Yining DaiDepartment of Cardiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Xuan TengShantou University Medical College, Shantou, China.
Weiyi KongStomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, China.
Zongrong LinDepartment of Cardiology, The First Affiliated Hospital of Guangdong Pharmaceutical University, The First Clinical Medical School of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, China.
Zhenyang Fu *Department of Cardiology, The First Affiliated Hospital of Guangdong Pharmaceutical University, The First Clinical Medical School of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, China.
Sicheng Chen *Department of Cardiovascular Disease, Shantou Hospital of Traditional Chinese Medicine, Shantou, China.
Jinjin Liu *Department of Cardiology, The First Affiliated Hospital of Guangdong Pharmaceutical University, The First Clinical Medical School of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Myocardial infarction (MI) and lung cancer frequently coexist within the broader context of cardio-oncology, yet the development, contributors, and thematic evolution of this research interface have not been comprehensively mapped. This study aimed to characterize the bibliometric landscape, collaboration patterns, thematic structure, and temporal evolution of MI and lung cancer research and to identify clinically relevant evidence gaps. Methods: English-language articles and reviews published from 1995 through June 2026 were retrieved independently from the Web of Science Core Collection (WoSCC) and PubMed. WoSCC served as the primary dataset for citation, collaboration, co-occurrence, co-citation, and thematic analyses, whereas PubMed was used for supplementary validation using biomedical indexing and Medical Subject Headings. Bibliometric analyses were performed using R/Bibliometrix, CiteSpace, VOSviewer, and Microsoft Excel. Results: After screening, 2,274 WoSCC records and 1,326 PubMed records were included. The annual growth rates were 0.91% and 3.35%, respectively. The United States contributed the largest publication output in both databases, followed by China, although the United States showed a stronger international collaboration profile. Harvard University led WoSCC institutional output, whereas Harvard Medical School ranked first in PubMed. Conclusions: Research at the MI-lung cancer interface has expanded substantially and increasingly reflects the cardiovascular implications of contemporary lung cancer care. Future work should prioritize prospective multicenter studies, standardized cardiovascular endpoints, and integrated strategies for risk assessment, surveillance, and management in patients with lung cancer who are vulnerable to ischemic cardiovascular events.

Indexed as

bibliometric analysiscardio-oncologycardiovascular complicationslung cancerMyocardial infarction (MI)

Identifiers

PMID42724690
PMCPMC13559346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.